News & Updates
Showing Endocrinology articles
Showing
Nutritional risk in older diabetes patients tied to diabetic retinopathy
A low geriatric nutritional risk index score seems to worsen the risk of proliferative diabetic retinopathy in older adults with type 2 diabetes, a recent study has found.
Nutritional risk in older diabetes patients tied to diabetic retinopathy
24 Jul 2022
Lower diabetes risk test cutoff ups lab cost, identifies more persons with prediabetes
Use of the American Diabetes Association (ADA) Diabetes Risk Test (DRT) cutoff score of 4 as part of an employee wellness screening program to identify individuals at risk for developing the disease adds up to laboratory costs, reports a study.
Lower diabetes risk test cutoff ups lab cost, identifies more persons with prediabetes
24 Jul 2022
Saliva biomarkers can help predict diabetic neuropathy in type 1 diabetes
Salivary levels of the inflammatory biomarker immunoglobulin A (IgA) appear to be significantly suppressed in type 1 diabetes mellitus (DM) patients with neuropathy (DMN), reports a recent study.
Saliva biomarkers can help predict diabetic neuropathy in type 1 diabetes
21 Jul 2022
Tirzepatide beneficial for shedding pounds in obese adults
Once-weekly treatment with tirzepatide in adults with obesity appears to yield substantial and sustained reductions in body weight, according to the phase III SURMOUNT-1 trial.
Tirzepatide beneficial for shedding pounds in obese adults
21 Jul 2022
Chronic hepatitis C tied to cardiovascular events in T2DM
In patients with type 2 diabetes mellitus (T2DM), chronic hepatitis C and fatty liver appear to worsen the risk of cardiovascular events, a recent Taiwan study has found.
Chronic hepatitis C tied to cardiovascular events in T2DM
19 Jul 2022
Resmetirom demos potential in NASH
Safety analysis of the phase III MAESTRO-NAFLD-1 trial presented at ILC 2022 demonstrated the potential of resmetirom as a treatment for patients with non-alcoholic steatohepatitis (NASH) who have liver fibrosis.